Diasorin signed a distribution agreement with McKesson Medical Surgical to push its Liaison Nes point‑of‑care PCR system into non‑acute settings, including physician office labs and decentralized testing sites. The system delivers PCR results in about 15 minutes and the deal aims to scale molecular testing beyond hospitals. Separately, WHO introduced a new diagnostic class—near‑point‑of‑care nucleic acid amplification tests (nPOC‑NAATs)—and highlighted Pluslife’s MiniDock MTB as the first member. The guidance endorses swab‑based sampling (including oral swabs) and devices tailored for hot, resource‑limited settings, potentially lowering barriers to TB molecular testing in decentralized care.